Metraipolis › archive › dc_ab86231c3ca5

Industry-defined opportunities for advancing big data capabilities in biopharmaceutical manufacturing — Europe PMC PMID:42761237

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42761237
DOI
10.3389/fbioe.2026.1886721
License (as archived)
solo-consultazione
Archived
2026-10-31T17:34:13.492Z
SHA-256 of the archived text
d82ea20fd3c7b236109517c04a99e0990f8c5d3ea0db11744f35706be2e71e43
Stable URL of this page
https://metraipolis.com/documento/dc_ab86231c3ca5

How to cite

Industry-defined opportunities for advancing big data capabilities in biopharmaceutical manufacturing — Europe PMC PMID:42761237 — Europe PMC (en), https://europepmc.org/article/MED/42761237 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ab86231c3ca5 (Metraipolis archive dc_ab86231c3ca5, sha256 d82ea20fd3c7b236109517c04a99e0990f8c5d3ea0db11744f35706be2e71e43)
BibTeX
@misc{dcab86231c3ca5,
  title = {Industry-defined opportunities for advancing big data capabilities in biopharmaceutical manufacturing — Europe PMC PMID:42761237},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42761237},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ab86231c3ca5; sha256 d82ea20fd3c7b236109517c04a99e0990f8c5d3ea0db11744f35706be2e71e43},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42761237. Agents can read the archived copy with the MCP tool read_document.